IRadimed Corporation
IRMD
$96.90
$0.640.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.48M | 21.18M | 20.66M | 19.78M | 19.23M |
| Total Depreciation and Amortization | 1.17M | 980.50K | 794.40K | 786.00K | 818.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.65M | 3.03M | 2.97M | 1.76M | 1.82M |
| Change in Net Operating Assets | -4.35M | -184.30K | 2.72M | 3.70M | 3.75M |
| Cash from Operations | 24.95M | 25.01M | 27.14M | 26.03M | 25.62M |
| Capital Expenditure | -7.77M | -10.26M | -12.93M | -11.43M | -8.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -655.90K | -800.50K | -876.10K | -823.60K | -812.00K |
| Cash from Investing | -8.42M | -11.06M | -13.81M | -12.26M | -8.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 25.70K | 25.70K | 29.00K | 29.00K |
| Repurchase of Common Stock | -2.56M | -784.20K | -772.40K | -740.30K | -687.90K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.04M | -8.39M | -8.12M | -7.86M | -13.68M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.60M | -9.15M | -8.87M | -8.57M | -14.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 1.00K | 1.00K | 1.00K | 1.00K |
| Net Change in Cash | -1.07M | 4.81M | 4.46M | 5.20M | 2.47M |